Gene expression profile of trisomy 21 placentas: A potential approach for designing noninvasive techniques of prenatal diagnosis

Susan J. Gross, Jose C. Ferreira, Bernice E. Morrow, Pe'er Dar, Birgit Funke, Dineo Khabele, Irwin R. Merkatz

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

OBJECTIVE: The purpose of this study was to evaluate the feasibility of the DNA microarray technology for the study of the differences in gene expression between placentas of pregnancies with trisomy 21 fetuses and placentas of fetuses with a normal karyotype. STUDY DESIGN: Complementary DNA samples from 7 second-trimester placentas of fetuses with trisomy 21 was compared with 7 matched and 7 nonmatched complementary DNA samples from normal karyotype placentas as control samples. For gene expression comparison, a microarray that contained 8976 expressed sequence tags was used. Four experiments were performed: (1) the study samples were compared with matched control samples; (2) the study samples were compared with nonmatched control samples; (3) the study samples were compared with themselves; and (4) the matched and nonmatched control samples were compared. Gene overexpression and underexpression were defined as sample signal differences of >1.7 over each other. Gene overexpression and underexpression were confirmed by Northern blotting studies. RESULTS: Seven expressed sequence tags of 8976 tags that were examined have met the selection criteria. Overexpression of 2 expressed sequence tags in placentas with trisomy 21 was confirmed by Northern blotting studies. CONCLUSION: Our study demonstrates the feasibility of the microarray technique in the study of the differences of gene expression in trisomic placentas compared with placentas with a normal karyotype. This technique may contribute to the identification of additional maternal serum biochemical markers in aneuploid pregnancies.

Original languageEnglish (US)
Pages (from-to)457-462
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume187
Issue number2
DOIs
StatePublished - Aug 2002

Fingerprint

Down Syndrome
Prenatal Diagnosis
Transcriptome
Placenta
Expressed Sequence Tags
Karyotype
Fetus
Gene Expression
Northern Blotting
Complementary DNA
Biomarkers
Pregnancy
Feasibility Studies
Second Pregnancy Trimester
Aneuploidy
Oligonucleotide Array Sequence Analysis
Patient Selection
Genes
Mothers
Technology

Keywords

  • Microarray
  • Placenta
  • Screening
  • Trisomy 21

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Gene expression profile of trisomy 21 placentas : A potential approach for designing noninvasive techniques of prenatal diagnosis. / Gross, Susan J.; Ferreira, Jose C.; Morrow, Bernice E.; Dar, Pe'er; Funke, Birgit; Khabele, Dineo; Merkatz, Irwin R.

In: American Journal of Obstetrics and Gynecology, Vol. 187, No. 2, 08.2002, p. 457-462.

Research output: Contribution to journalArticle

@article{f4eafb4089134c75a5035030fc9a25cc,
title = "Gene expression profile of trisomy 21 placentas: A potential approach for designing noninvasive techniques of prenatal diagnosis",
abstract = "OBJECTIVE: The purpose of this study was to evaluate the feasibility of the DNA microarray technology for the study of the differences in gene expression between placentas of pregnancies with trisomy 21 fetuses and placentas of fetuses with a normal karyotype. STUDY DESIGN: Complementary DNA samples from 7 second-trimester placentas of fetuses with trisomy 21 was compared with 7 matched and 7 nonmatched complementary DNA samples from normal karyotype placentas as control samples. For gene expression comparison, a microarray that contained 8976 expressed sequence tags was used. Four experiments were performed: (1) the study samples were compared with matched control samples; (2) the study samples were compared with nonmatched control samples; (3) the study samples were compared with themselves; and (4) the matched and nonmatched control samples were compared. Gene overexpression and underexpression were defined as sample signal differences of >1.7 over each other. Gene overexpression and underexpression were confirmed by Northern blotting studies. RESULTS: Seven expressed sequence tags of 8976 tags that were examined have met the selection criteria. Overexpression of 2 expressed sequence tags in placentas with trisomy 21 was confirmed by Northern blotting studies. CONCLUSION: Our study demonstrates the feasibility of the microarray technique in the study of the differences of gene expression in trisomic placentas compared with placentas with a normal karyotype. This technique may contribute to the identification of additional maternal serum biochemical markers in aneuploid pregnancies.",
keywords = "Microarray, Placenta, Screening, Trisomy 21",
author = "Gross, {Susan J.} and Ferreira, {Jose C.} and Morrow, {Bernice E.} and Pe'er Dar and Birgit Funke and Dineo Khabele and Merkatz, {Irwin R.}",
year = "2002",
month = "8",
doi = "10.1067/mob.2002.123542",
language = "English (US)",
volume = "187",
pages = "457--462",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Gene expression profile of trisomy 21 placentas

T2 - A potential approach for designing noninvasive techniques of prenatal diagnosis

AU - Gross, Susan J.

AU - Ferreira, Jose C.

AU - Morrow, Bernice E.

AU - Dar, Pe'er

AU - Funke, Birgit

AU - Khabele, Dineo

AU - Merkatz, Irwin R.

PY - 2002/8

Y1 - 2002/8

N2 - OBJECTIVE: The purpose of this study was to evaluate the feasibility of the DNA microarray technology for the study of the differences in gene expression between placentas of pregnancies with trisomy 21 fetuses and placentas of fetuses with a normal karyotype. STUDY DESIGN: Complementary DNA samples from 7 second-trimester placentas of fetuses with trisomy 21 was compared with 7 matched and 7 nonmatched complementary DNA samples from normal karyotype placentas as control samples. For gene expression comparison, a microarray that contained 8976 expressed sequence tags was used. Four experiments were performed: (1) the study samples were compared with matched control samples; (2) the study samples were compared with nonmatched control samples; (3) the study samples were compared with themselves; and (4) the matched and nonmatched control samples were compared. Gene overexpression and underexpression were defined as sample signal differences of >1.7 over each other. Gene overexpression and underexpression were confirmed by Northern blotting studies. RESULTS: Seven expressed sequence tags of 8976 tags that were examined have met the selection criteria. Overexpression of 2 expressed sequence tags in placentas with trisomy 21 was confirmed by Northern blotting studies. CONCLUSION: Our study demonstrates the feasibility of the microarray technique in the study of the differences of gene expression in trisomic placentas compared with placentas with a normal karyotype. This technique may contribute to the identification of additional maternal serum biochemical markers in aneuploid pregnancies.

AB - OBJECTIVE: The purpose of this study was to evaluate the feasibility of the DNA microarray technology for the study of the differences in gene expression between placentas of pregnancies with trisomy 21 fetuses and placentas of fetuses with a normal karyotype. STUDY DESIGN: Complementary DNA samples from 7 second-trimester placentas of fetuses with trisomy 21 was compared with 7 matched and 7 nonmatched complementary DNA samples from normal karyotype placentas as control samples. For gene expression comparison, a microarray that contained 8976 expressed sequence tags was used. Four experiments were performed: (1) the study samples were compared with matched control samples; (2) the study samples were compared with nonmatched control samples; (3) the study samples were compared with themselves; and (4) the matched and nonmatched control samples were compared. Gene overexpression and underexpression were defined as sample signal differences of >1.7 over each other. Gene overexpression and underexpression were confirmed by Northern blotting studies. RESULTS: Seven expressed sequence tags of 8976 tags that were examined have met the selection criteria. Overexpression of 2 expressed sequence tags in placentas with trisomy 21 was confirmed by Northern blotting studies. CONCLUSION: Our study demonstrates the feasibility of the microarray technique in the study of the differences of gene expression in trisomic placentas compared with placentas with a normal karyotype. This technique may contribute to the identification of additional maternal serum biochemical markers in aneuploid pregnancies.

KW - Microarray

KW - Placenta

KW - Screening

KW - Trisomy 21

UR - http://www.scopus.com/inward/record.url?scp=0036677986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036677986&partnerID=8YFLogxK

U2 - 10.1067/mob.2002.123542

DO - 10.1067/mob.2002.123542

M3 - Article

C2 - 12193943

AN - SCOPUS:0036677986

VL - 187

SP - 457

EP - 462

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -